Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationView the streams from last week's FDA, MHRA, Health Canada Symposium
Available now on the ICH website The ICH E2D(R1) draft Guideline on “Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports (ICSRs)” reached Step 2b of the ICH Process in February 2024 and entered the consultation period.
Dame June Raine, MHRA's Chief Executive, will be stepping down in the Autumn following five years in the role
Process changes from 1 March 2024 build on measures already implemented by the agency
EMA consultations open for comment now.
GMP for API
Draft guidance, Released January 2024.
Draft guidance, Feb 2024.
Med Tech Regulatory Reform: The first steps towards a new framework for medical devices in the UK
28 February 2024